Correction to: Bone‑targeted erythrocyte‑cancer hybrid membrane‑camouflaged nanoparticles for enhancing photothermal and hypoxia‑activated chemotherapy of bone invasion by OSCC
J Nanobiotechnology. 2022 Jan 3;20(1):2.
doi: 10.1186/s12951-021-01185-9.